Fertility warning
This medicine may affect fertility.
Leaflet DACARBAZINA LIPOMED 500mg powder for solution for infusion
- Product code:
- W63916001
- Quantity:
- 1
- Indicated for:
- cancer
- Route of administration:
- infusion
- Substance:
- dacarbazine (alkylating antineoplastic agent)
- ATC
- L01AX04 — Antineoplastic and immunomodulating agents | Alkylating agents | Other alkylating agents
Precautions:
Dose adjustment in hepatic impairment
Dose adjustment may be needed in liver disease.
Cytotoxic / special handling
Handle with special care.
Contraception required
Effective contraception is required during treatment.
Contraindicated during breastfeeding
Do not use this medicine while breastfeeding.
Contraindicated during pregnancy
Do not use this medicine during pregnancy.
Hepatotoxicity
This medicine may affect the liver.
Major drug interactions
This medicine may have important interactions with other medicines.
Myelosuppression / agranulocytosis
This medicine may lower blood cell counts.
Additional monitoring
This medicine is subject to additional monitoring.
Requires periodic laboratory tests
Periodic laboratory tests may be required during treatment.
Severe skin reactions
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
Dacarbazine is a chemotherapy medication used for the treatment of malignant melanoma, Hodgkin's disease, and other types of cancer. It acts as an alkylating agent, interfering with DNA synthesis and inhibiting cell division.
The medication is administered via intravenous infusion, with the dose determined by the physician based on the type of cancer and the patient's overall condition. Common side effects include nausea, vomiting, fatigue, and bone marrow suppression.
Dacarbazine is contraindicated in patients with hypersensitivity to the active substance or any of its excipients. It should also be used with caution in patients with hepatic or renal impairment.
This medication is an important option in cancer treatment, helping to reduce tumor size and improve the prognosis of affected patients.
The medication is administered via intravenous infusion, with the dose determined by the physician based on the type of cancer and the patient's overall condition. Common side effects include nausea, vomiting, fatigue, and bone marrow suppression.
Dacarbazine is contraindicated in patients with hypersensitivity to the active substance or any of its excipients. It should also be used with caution in patients with hepatic or renal impairment.
This medication is an important option in cancer treatment, helping to reduce tumor size and improve the prognosis of affected patients.
General data about DACARBAZINA LIPOMED 500mg
- Substance:
- dacarbazine
- Date of latest medicines list:
- 01-12-2017
- Product code:
- W63916001
- Concentration:
- 500mg
- Pharmaceutical form:
- powder for solution for infusion
- Quantity:
- 1
- Product type:
- Generic medicine
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for dacarbazine
Concentrations available for dacarbazine
- 1000mg
- 100mg
- 200mg
- 500mg